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Abstract
Background: The effect of antioxidants on breast cancer is still controversial. Our objective was to assess the
association between antioxidants and breast cancer risk in a large population-based case-control study.
Methods: The study population included 2,362 cases with pathologically confirmed incident breast cancer (866
premenopausal and 1,496 postmenopausal) and 2,462 controls in Canada. Intakes of antioxidants from diet and
from supplementation as well as other potential risk factors for breast cancer were collected by a self-reported
questionnaire.
Results: Compared with subjects with no supplementation, 10 years or longer supplementation of zinc had
multivariable-adjusted odds ratios (OR) and 95% confidence intervals (CI) of 0.46 (0.25-0.85) for premenopausal
women, while supplementation of 10 years or longer of multiple vitamin, beta-carotene, vitamin C, vitamin E and
zinc had multivariable-adjusted ORs (95% CIs) of 0.74 (0.59, 0.92), 0.58 (0.36, 0.95), 0.79 (0.63-0.99), 0.75 (0.58, 0.97),
and 0.47 (0.28-0.78), respectively, for postmenopausal women. No significant effect of antioxidants from dietary
sources (including beta-carotene, alpha-carotene, lycopene, lutein and zeaxanthin, vitamin C, vitamin E, selenium
and zinc) or from supplementation less than 10 years was observed.
Conclusions: This study suggests that supplementation of zinc in premenopausal women, and supplementation of
multiple vitamin, beta-carotene, vitamin C, vitamin E and zinc in postmenopausal women for 10 or more years may
protect women from developing breast cancer. However, we were unable to determine the overall effect of total
dose or intake from both diet and supplement.
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Background
Breast cancer is the most common cancer and the second
leading cause of cancer-related death among Canadian
women [1]. According to the most recent projection
from Canadian Cancer Society, there will be 22,700 new
cases of female breast cancer representing 27.9% of all
cancer cases in women, and 5,400 deaths caused by
breast cancer accounting for 15.1% of all cancer-related
deaths in women in Canada in 2009 [1].
Recently, antioxidants such as vitamin A and its pre-
cursor (beta-carotene, lycopene, lutein, etc), vitamins C,
E, and selenium, have drawn a lot of attention to the
scientists and the public alike [2,3]. They have been
shown in experimental studies to neutralize or trap reac-
tive oxygen species (also known as free radicals), thereby
preventing cellular damage caused by the reaction of
these species with proteins and nucleic acids [4-9].
Inflammation, infection, extreme exercise and exposure
to various environmental factors, including pollution,
tobacco smoke and radiation, can increase the level of
free radicals in the body [3]. Excess production of free
radicals and/or deficiency of the antioxidant defence sys-
tem can result in oxidative stress, causing damage to
DNA and other molecules [4,5]. Over time, such damage
may become irreversible and may lead to diseases such as
cancer. There is evidence showing that oxidative stress
and lipid peroxidation are linked to the aetiology of
breast cancer [5]. Antioxidants are often described as
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oxidative stress and oxidative DNA damage [4,6,7,9]. It
has also been shown that antioxidants may selectively
induce apoptosis in cancer cells but spare normal cells,
and inhibit cell proliferation [3,10,11].
Although there is considerable evidence of anticancer
effect of antioxidants from cell culture and animal studies,
the results from observational studies and intervention
trials are inconsistent [8,12,13]. A recent review conducted
by Michels et al summarized the findings from prospective
observational studies of the role of diet on the risk of
breast cancer, including antioxidants, and found that the
reported results were not consistent and sometimes con-
troversial regarding the association between breast cancer
incidence and any dietary antioxidants and blood antioxi-
dants [2]. Randomized clinical trials of the effects of anti-
oxidants on chronic diseases including breast cancer, also
reached inconsistent conclusions [8,13,14]. However, since
antioxidant enhancement, either through increased dietary
intake or by supplementation, is a preventive measure that
can be easily implemented, further studies to look at this
association are warranted. The objective of this study was
to assess the association between antioxidants from both
diet and supplement and breast cancer, using data from a
large population based case-control study in Canada.
Methods
Study population
This study was based on data collected by the National
Enhanced Cancer Surveillance System (NECSS). The
details of NECSS, including the study design, study popu-
lation, and data collection strategies, have been published
elsewhere [15], and are briefly described here. The NECSS
was a multi-component, collaborative project of Health
Canada and the provincial cancer registries. The case-
control component included individual data from 21,020
Canadians with one of 19 types of cancers (including 2362
cases with breast cancer) and 5,039 population controls
(including 2492 females and 2647 males) aged 20- 76
years, which were collected between 1994 and 1997 in
eight of the 10 Canadian provinces (Alberta, British
Columbia, Manitoba, Newfoundland, Nova Scotia,
Ontario, Prince Edward Island and Saskatchewan). The
respective ethics review boards of each province reviewed
and approved the study proposal. The current analysis was
based on 2,362 incident cases of breast cancer (866 preme-
nopausal and 1,496 postmenopausal) and 2,462 controls
from all eight provinces.
The population-based provincial cancer registries
identified breast cancer cases through a review of
pathology reports. All cases were pathologically con-
firmed incident breast cancer patients, newly diagnosed
between 1994 and 1997 in the eight participating pro-
vinces. Breast cancer was defined as C50 according to
the International Classification of Diseases for Oncology,
Second Edition (ICD-O-2). The cancer registries tried to
identify cases as soon as possible after diagnosis to
reduce the loss of subjects caused by severe illness and
death. Provincial cancer registries identified 3386
women with breast cancer. Physician consent to contact
the cases was requested for 3248 cases. Seventy-four
women had died at the time of the physician request,
and the physician refused consent for another 224 cases.
Questionnaires were sent to 3013 cases and 2982 cases
were contacted. Completed questionnaires were received
from 2362 cases, representing 78.4% of cases who were
sent questionnaires and 69.7% of those ascertained.
Control subjects were women with no prior diagnosis of
cancer and residents of the participating provinces. In
NECSS, frequency matching to the overall case group (19
types of cancers) was used to select population controls
with similar age and sex distribution, so that there would
be at least one control for every case within each sex and
5-year age group for any specific cancer site within each
province. The sampling strategy for control selection var-
ied by province, depending on data availability, data qual-
ity (completeness and timeliness) and the confidentiality
restrictions of provincial databases. Prince Edward Island,
Nova Scotia, Manitoba, Saskatchewan, and British Colum-
bia used provincial health insurance plans to get a random
sample of the provincial population stratified by age group
and sex. More than 95% Canadians are covered by these
public plans, and individuals are excluded only if covered
through other federal plans. In Ontario, the Provincial
Ministry of Finance Property Assessment databases, which
are intended to include all residents of the province and
are updated monthly, were used to obtain a stratified ran-
dom sample. Newfoundland and Alberta used similar ran-
dom digit dialling protocols to obtain population samples.
Questionnaires were mailed to 3847 women selected
as potential controls. For 286 of these women 7.4%, the
mailed questionnaires were returned to the registry indi-
cating a wrong or old address, and no updated address
c o u l db ef o u n dt h r o u g hp u b l i c l ya v a i l a b l es o u r c e s .I n
total, 2492 women completed and returned the ques-
tionnaire, representing 71.3% of those contacted and
64.8% of these ascertained.
Data collection
The provincial registries collected data by self-adminis-
tered questionnaires, with telephone follow-up when
necessary for clarification and completeness. The ques-
tionnaires were designed to obtain detailed data on poten-
tial risk factors for cancers. The questionnaires collected
information on education, average family income over the
last 5 years, marital status, ethnic group, smoking, height,
weight, physical activity, alcohol consumption, diet (69-
item food frequency questions) 2 years before interview,
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past 20 years. Questionnaires also gathered information
about menstrual and reproductive history and residential
history.
Assessment of dietary intake
The diet component of the questionnaire used a 69-item
food frequency instrument to collect information on diet
from 2 years before the interview date. The design of the
diet component of the questionnaire was based on two
validated instruments: the National Cancer Institute’s
Block Questionnaire [16], and the instrument used in the
Nurses’ Health Study cohort [17], with minor modifica-
tions to account for the differences between the Cana-
dian and American diet. These two instruments have
been widely used in studies on diet and cancer.
A commonly used portion or serving size was specified
for each food or beverage item. Respondents indicated the
usual frequency of consumption of that portion size for
each food item by selecting one of nine possible categories:
0 or < 1 per month, 1 to 3 per month, 1 per week, 2 to
4 per week, 5 to 6 per week, 1 per day, 2 to 3 per day, 4 to
5p e rd a y ,o r≥ 6 per day. The weekly consumption of
each food item was then calculated as the product of fre-
quency and serving size. The nutrient content of foods
was determined using food composition data from the
Canadian Nutrient Guide and Canadian Nutrient File
[18]). The total weekly intake level of each nutrient was
determined by multiplying the weekly consumption quan-
tity of each food item by its associated nutrient value, and
calculating the sum of the weekly nutrient intake levels for
all 69 food items.
The questionnaire also collected information regarding
vitamin or mineral supplement use (frequency and length)
during the past 20 years. Respondents were asked how
often (never, not regularly, and fairly regularly) and for
how many years in total they had taken each of the 10
vitamins and mineral supplements (less than 1 year, 1-2
years, 3-5 years, 6-9 years, 10-19 years, and 20+ years).
The ten vitamins and minerals are multiple vitamins, vita-
min A, vitamin C, vitamin E, B-complex vitamins, beta-
carotene, calcium, iron, zinc, and selenium.
Assessment of other variables
The questionnaire gathered information on recreational
physical activity 2 years before interview. Respondents
were asked in which seasons, how often and how long per
session, on average, they participated in each of the 12
most common types of leisure-time physical activity in
Canada. Individual activities included walking for exercise,
bowling or curling, social dancing, gardening or yard
work, golf, home exercise or exercise class, bicycling, jog-
ging or running, racquet sports, swimming or water exer-
cise, skiing or skating, and other strenuous exercise.
Respondents indicated their usual frequency of participat-
ing in each of the above activities by choosing one of the
following categories: never, less than once per month, 1 -
3 times per month, 1 - 2 times per week, 3 - 6 times per
week or every day.
As a measure of overweight and obesity, body mass
index (BMI) was calculated as the reference weight in
kilograms (2 years before interview) divided by height in
meters squared.
Statistical analysis
We estimated the risk of breast cancer associated with
intake of dietary antioxidants (beta-carotene, lycopene,
lutein, vitamin C, vitamin E, and selenium) and with years
of supplementation of antioxidants (multiple vitamin, vita-
min A, beta-carotene, vitamin C, vitamin E, and selenium)
based on odds ratios (ORs) and corresponding 95% confi-
dence intervals (CIs), using unconditional logistic regres-
sion with the software package SAS (version 9; SAS
Institute, Inc., Cary, North Carolina). For antioxidants
from dietary intake, exposure variables were categorized
into quartiles based on the distribution of the variables in
the control population, with the lowest quartile as the
reference. For antioxidants from supplementation, expo-
sure variables were categorized by length of supplementa-
tion (never taken, ≤ 2 years, 3-9 years, and ≥ 10 years, with
never taken as the reference). Total intake of antioxidants
was examined in following way: high (equal to or high
than median) versus low (lower than median) intake of
a n t i o x i d a n tf r o md i e to n l y ,h i g h( ≥ 10 years) versus low
(< 10 years) intake from supplementation only, and high
intake from both diet (equal to or high than median) and
supplementation (≥ 10 years) versus low intake (from
either sources). The analysis was performed for premeno-
pausal and postmenopausal breast cancers separately. We
conducted tests for trends for all models of categorized
data by treating the different categories as a single ordinal
variable.
Because cases and controls were not directly matched,
the methods for identifying cases and controls varied by
province; and, because age is associated with breast can-
cer risk, all logistic regression analyses were controlled
for province of residence and age to remove the impact
of any uneven distribution of these factors between cases
and controls. We used the change-in-point-estimate
approach to assess the potential confounding effect of a
wide range of factors, including age, family income, edu-
cational level, alcohol consumption, smoking, BMI, total
calorie intake, recreational physical activity level, meno-
pausal status, and number of live births. We retained
variables in the final models that are considered biologi-
cally important if their inclusion changed the odds ratio
estimate appreciably, regardless of the statistical signifi-
cance. We adjusted the final multivariate models for age
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(years, continuous), number of live births (none, 1, 2, 3,
and > = 4), age at menarche (years, continuous), alcohol
consumption (servings per week, continuous), pack-years
of smoking (continuous) and total calorie intake (kilocal-
ories per week, continuous). For postmenopausal women,
the models were also adjusted for BMI and recreational
physical activity. Mutual adjustments were done for ana-
lyses on antioxidants from dietary source and from
supplementation.
Results
Data from 2,362 breast cancer cases (866 premenopausal
cases and 1,496 postmenopausal cases) and 2,462 con-
trols were available for analysis.
Table 1 shows the distribution of some selected char-
acteristics of breast cancer cases and controls. For pre-
menopausal women, compared with controls, cases were
slightly older and had less live birth and longer years of
menstruation. For postmenopausal women, compared
with controls, cases were slightly younger and had
higher education, longer smoking pack-years, higher
alcohol consumption, higher BMI, less live births, and
longer years of menstruation.
Table 2 shows the average intakes of antioxidants from
diet and average years of antioxidant supplementation.
The average intakes of beta-carotene, vitamin C, vitamin
E, selenium and zinc from diet and average years of sup-
plementation were similar for cases and controls for both
premenopausal and postmenopausal women.
Table 3 presents the breast cancer risk associated with
different levels of antioxidants from dietary intake
including beta-carotene, alpha-carotene, lycopene, lutein
and zeaxanthin, vitamin C, vitamin E, selenium and
zinc. No significant association was observed between
breast cancer risk and the highest quartiles of these anti-
oxidant intakes from dietary sources compared with the
lowest quartiles of intake, either for premenopausal or
for postmenopausal breast cancer.
Table 4 shows the breast cancer risk associated with dif-
ferent categories (years) of antioxidants from supplemen-
tation. For premenopausal breast cancer, supplementation
of 10 years or longer was associated with statistically sig-
nificant reduction in breast cancer risk for zinc. For post-
menopausal breast cancer, supplementation of 10 years or
longer was associated with statistically significant reduc-
tion in breast cancer risk for multiple vitamin, beta-caro-
tene, vitamin C, vitamin E and zinc. No significant
association between antioxidants and risk of breast cancer,
in either premenopausal or postmenopausal cases, was
observed, for supplementation less than 10 years prior to
data collection, however.
Table 5 gives the odds ratios of breast cancer asso-
ciated with high intakes of beta-carotene, vitamin C,
vitamin E, zinc, and selenium from diet only, from sup-
plementation only and from both sources. High intakes
of beta-carotene, vitamin C, vitamin E, Zinc, and sele-
nium from diet only were not significantly associated
with breast cancer risk compared with low intake of
these antioxidants for both premenopausal and postme-
nopausal women. Results for high intake of these anti-
oxidants from supplementation only were similar to
table 3. High intakes from both sources were not signifi-
cantly associated with breast cancer risk except for vita-
min C in premenopausal women and for zinc in
postmenopausal women.
Discussion
Our large population based study indicated that supple-
mentations of 10 years or longer with zinc were associated
with statistically significant reductions in premenopausal
breast cancer risk. For postmenopausal women, supple-
mentations of 10 years or longer of multiple vitamins,
beta-carotene, vitamin C, vitamin E and zinc were asso-
ciated with statistically significant reductions for breast
cancer risk. No significant difference was observed in
breast cancer risk, either premenopausal or postmenopau-
sal, across different levels of antioxidants from dietary
sources, nor was there a significant effect of supplementa-
tion shorter than 10 years. With the ability to draw a
national sample, our study is amongst the largest in the
field. We have also been able to adjust for a number of
risk factors known to be related to breast cancer such as
BMI, energy intake, and physical activity. However, this
study could not determine the overall effect of total dose
or intake of antioxidants from both diet and supplement.
Carotenoids (precursor of vitamin A) include alpha-
carotene, beta-carotene, lutein, lycopene, and beta-
cryptoxanthin. Higher dietary intakes and blood
concentrations of carotenoids, including beta-carotene,
have been shown to reduce breast cancer risk, but the
results are not entirely consistent [8,19]. A summarized
analysis of 8 case-control studies showed a 15% reduc-
tion in breast cancer risk associated with the highest
category of dietary beta-carotene [20]. A meta-analysis
of 11 studies published from 1982 to 1997 also sug-
gests that intake of 7000 μgp e rd a yo rm o r eo fb e t a -
carotene was associated with 18% reduction of breast
cancer risk compared with intake of 1000 μgp e rd a y
or less [21]. In addition, a nested case-control study
reported a 50% decrease in breast cancer risk in
women with high levels of serum beta-carotene, lyco-
pene, and total carotene compared with those with low
levels of these micronutrients [22]. Higher serum beta-
carotene concentration was also found to be associated
with lower breast cancer risk in other cohort studies
[23-26] and case-control studies [27,28]. However, no
association was observed in some studies for serum
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alpha-carotene, lutein, beta-cryptoxanthin and lycopene
[12,31] and in one randomized trail on beta-carotene
supplementation use [13]. The Women’s Health Initia-
tive Observational Study on postmenopausal women
also suggests that the association between breast can-
cer risk and carotenoids differs by estrogen receptor
(ER) and progesterone receptor (PR) status since this
study found that dietary alpha-carotene and beta-caro-
tene were inversely associated with the risk of ER+PR+
breast cancer only, but not with other breast cancer
groups defined by ER and PR status [32]. Carotenoids
have been shown to protect against DNA alterations
via a decrease in oxidative and other damage to DNA
in humans [3,6,7,11] and protect cells in vitro against
neoplastic transformation [3,11].
Zinc is involved with metallothionine synthesis, which
is believed to inhibit free radical production [33]. Zinc
supplementation has also been shown to reduce oxidative
stress and DNA strand breaks and early and delayed
apoptosis, as well as improve immune function [33]. Two
case- control studies [34,35] demonstrated statistically
significant inverse associations between Zn exposure,
measured in serum and diet, respectively, and breast can-
cer risk. However, two nested case- control studies
[36,37] reported no association between toenail Zn or
Table 1 Comparison of cases and controls on demographics and potential confounding factors, NECSS, Canada, 1994-
1997
Premenopausal Postmenopausal
Characteristic Cases
(N = 866)
Controls
(N = 845)
P Cases(1496) Controls
(n = 1617)
P
Age (mean ± SD) 44.8 ± 6.2 43.8 ± 7.6 0.003 62.0 ± 8.5 62.7 ± 8.1 0.03
Education (years) (mean ± SD) 13.5 ± 3.1 13.6 ± 3.3 0.51 11.7 ± 3.4 11.3 ± 3.5 0.0009
Smoking pack-years (mean ± SD) 5.9 ± 9.4 5.8 ± 9.4 0.72 10.5 ± 15.0 8.8 ± 14.4 0.001
Alcohol consumption (drinks/wk) (mean ± SD)) 2.9 ± 5.7 2.7 ± 5.1 0.48 3.1 ± 6.7 2.5 ± 5.6 0.01
BMI (kg/m
2 ) (mean ± SD) 24.7 ± 5.2 24.5 ± 4.8 0.29 26.1 ± 5.9 25.7 ± 5.5 0.03
Moderate physical Activity (frequency/month (mean ±
SD))
15.9 ± 14.9 15.7 ± 14.1 0.67 18.6 ± 15.4 18.0 ± 15.9 0.28
Strenuous physical activity (frequency/month (mean ±
SD))
4.8 ± 8.4 4.9 ± 8.0 0.77 3.3 ± 7.8 3.5 ± 8.1 0.42
Total energy intake (kcals/week) 12915 ± 4791 12687 ± 5440 0.35 12965 ±
5333
12775 ± 6997 0.39
Years of menstruation (mean ± SD) 32.0 ± 6.2 30.9 ± 7.7 0.001 33.0 ± 7.7 32.4 ± 7.6 0.02
Age at menarche (mean ± SD) 12.6 ± 1.4 12.8 ± 1.5 0.005 12.8 ± 1.6 13.0 ± 1.7 0.01
Marital status 0.89 < 0.0001
Marred 659 621 1003 1057
Common law 51 44 19 27
Divorced/separated 74 97 136 129
Windowed 16 18 248 340
Single 60 59 86 59
Other 4 4 2 2
No. live birth 0.27 < 0.0001
0- 162 168 230 174
1- 118 107 153 143
2- 366 330 400 395
3- 162 146 338 319
≥ 4 56 93 372 581
Family income adequacy 0.05 0.17
Low 102 111 283 306
Low middle 146 138 234 276
Upper middle 274 259 302 317
High 202 155 217 199
Smoking status 0.72 0.006
Never 409 413 697 826
Ex-smoker 267 221 488 505
Current smoker 190 211 311 286
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Another case-control study also found no difference in
either hair or plasma level of zinc between cases and con-
trols [38]. The use of different status biomarkers in these
studies may explain partly the mixed results of different
studies [39].
Although studies in cell cultures and animals showed
that vitamin E and C prevent transformation of normal
cells to cancer cells and selectively induce apoptosis in
cancer cells, the results of epidemiologic studies have
been inconsistent [19]. The review of 12 cohort studies
on dietary vitamin C and vitamin E intake and the inci-
dence of breast cancer suggested no consistent associa-
tion between both vitamin and breast cancer incidence
among these studies [2]. The Danish Diet Cancer and
Health Cohort observed a significant inverse association
for total vitamin E (including dietary and supplemental)
intake among postmenopausal women (RR = 0.59, 95%
CI: 0.37-0.95) [40]. An inverse association between breast
cancer risk and high serum level of alpha-tocopherol
(vitamin E) was also found in 3 cohort studies [24,26,41].
However, several cohort studies reported no significant
association [22,29,30,32,42-45]. The evidence for vitamin
C is also inconsistent. A pooled analysis of 9 case-control
studies found a 31% decrease in breast cancer risk asso-
ciated with each 300 mg of vitamin C per day [20]. A
meta-analysis of 9 case-control and cohort studies
observed a summary RR of 0.80 (95% CI: 0.68-0.95) for
high consumption compared with low consumption [21].
On the other hand, several cohort studies reported no
significant association between vitamin C and breast can-
cer risk [32,42-45]. One randomized controlled trial
found no relationship of vitamin C and E supplementa-
tion use with breast cancer risk [13].
Because of differences in study population, study design,
and nutritional assessment, it is rather difficult to reconcile
results from different studies. Our study did not find any
association between any antioxidant from dietary sources
and breast cancer risk, or an effect of supplementation
shorter than 10 years on breast cancer risk, for both pre-
menopausal and postmenopausal cases. It is difficult to
measure nutrients from dietary intake by case control stu-
dies. Although the response rate was 69.7% for breast can-
cer cases, selection (inclusion) of cases was not related to
exposure status (i.e. antioxidant intake), therefore, selec-
tion bias is unlikely to occur. Recall bias, inherent in all
case-control design, is possible because cases might bias
their responses to questions on diet after a few months of
cancer diagnosis. The possibility that such a bias was
introduced into our study was reduced by including many
questions on other exposures, such as socio-demographic
factors, physical activity, weight, smoking history, employ-
ment history and residential history and by not placing
any particular emphasis on diet in the questionnaire.
Although we used a widely validated questionnaire, mea-
surement error of dietary intakes, for example, self-reports
of long-term dietary supplements, could introduce mis-
classification in exposure status, but it is likely to be non-
differential. The 69-item food frequency questionnaire
might fail to capture all kinds of food consumed and
underestimated total dietary intake. The time window of
exposure is also critical in epidemiologic studies of dis-
eases with long incubation period such as breast cancer.
To improve accuracy and precision, we used two year
from diagnosis as the point of measurement in the dietary
survey. Another limitation is that we could not assess the
dose of antioxidants from supplementation because doses
of antioxidants from different producers, years and batches
Table 2 Average intakes of antioxidants by case-control status, NECSS, Canada, 1994-1997
Premenopausal Postmenopausal
Characteristic Cases (N = 866) Controls (N = 845) p Cases(1496) Controls (n = 1617) P
Mean Mean Mean Mean
From diet
Beta-carotene (μg/wk) 31643.6 32369.8 0.55 37831 37648.6 0.89
Vitamin E (mg/wk) 56.4 56.8 0.82 64.2 62.6 0.37
Vitamin C (mg/wk) 1101.2 1137.1 0.38 1184.8 1151.3 0.26
Selenium (μg/wk) 660.2 651.6 0.54 662.9 656.9 0.65
Zinc (mg/wk) 65.7 64.9 0.52 67.1 65.7 0.27
From supplement (years)
Vitamin A 0.88 1.02 0.38 1.02 1.06 0.76
Beta-carotene 0.59 0.77 0.16 0.68 0.76 0.39
Vitamin C 3.22 3.53 0.24 3.85 3.68 0.44
Vitamin E 1.53 1.80 0.16 2.61 2.72 0.56
Zinc 0.60 0.83 0.09 0.57 0.71 0.14
Selenium 0.37 0.47 0.33 0.41 0.41 0.95
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Pre-menopausal Post-menopausal
Nutrient Quartiles of intake Quartiles of intake
Q1* Q2 Q3 Q4 p for Q1* Q2 Q3 Q4 p for
OR† (95% CI) OR† (95% CI) OR† (95% CI) trend OR†† (95% CI) OR†† (95% CI) OR†† (95% CI) trend
Carotenoids
Beta-carotene (μg/wk)# 1.00 0.87 (0.65-1.15) 0.97 (0.73-1.28) 0.87 (0.65-1.17) 0.55 1.00 0.89 (0.72-1.10) 0.84 (0.68-1.04) 0.85 (0.68-1.06) 0.13
Alpha-carotene (μg/wk) 1.00 0.82 (0.61-1.10) 0.95 (0.72-1.25) 0.85 (0.64-1.14) 0.46 1.00 0.86 (0.72-1.11) 0.89 (0.71-1.12) 0.92 (0.73-1.14) 0.53
Lycopene (μg/wk) 1.00 0.97 (0.74-1.28) 0.99 (0.76-1.31) 0.88 (0.65-1.20) 0.53 1.00 1.15 (0.93-1.43) 1.20 (0.97-1.49) 1.21 (0.96-1.51) 0.14
Lutein and Zeaxanthin (μg/wk) 1.00 0.92 (0.69-1.23) 1.08 (0.82-1.44) 0.82 (0.61-1.11) 0.41 1.00 0.81 (0.64-1.02) 0.94 (0.75-1.19) 0.94 (0.74-1.19) 0.86
Beta cryptozanthin (μg/wk) 1.00 1.20 (0.89-1.60) 1.15 (0.87-1.53) 1.18 (0.86-1.60) 0.38 1.00 1.21 (0.98-1.50) 1.13 (0.90-1.40) 1.31 (1.04-1.65) 0.05
Vitamin C (mg/wk) # 1.00 1.00 (0.75-1.35) 1.21 (0.92-1.61) 0.87 (0.64-1.20) 0.89 1.00 1.13 (0.91-1.40) 1.14 (0.91-1.42) 1.24 (0.98-1.56) 0.09
Vitamin E (mg/wk) # 1.00 1.26 (0.93-1.70) 1.22 (0.89-1.68) 0.88 (0.62-1.25) 0.43 1.00 0.93 (0.75-1.15) 0.93 (0.74-1.17) 0.92 (0.73-1.17) 0.54
Selenium (μg/wk) # 1.00 1.22 (0.91-1.63) 1.23 (0.90-1.68) 1.10 (0.75-1.61) 0.58 1.00 1.21 (0.99-1.53) 1.10 (0.88-1.39) 1.09 (0.84-1.43) 0.73
Zinc (mg/wk) # 1.00 1.05 (0.78-1.41) 1.14 (0.83-1.57) 1.18 (0.79-1.77) 0.35 1.00 1.07 (0.85-1.35) 1.07 (0.84-1.36) 1.21 (0.91-1.71) 0.23
* Reference category
† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, number of live births, age at menarche, and total energy intake.
†† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, BMI, recreational physical activity, number of live births, age at menarche, and total energy intake.
# Also adjusted for years of taking antioxidants from supplementation.
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2may be different. This might also affect accuracy and pre-
cision of our results. Antioxidants, either from dietary
intake or from supplementation, may exert their effect
over a long period of time. That may be the reason why
we observed the effect for supplementation of 10 years or
longer only. In addition, we could not adjust for the family
history of breast cancer, benign breast disease, oral contra-
ceptive use, hormone replacement therapy, and hormone
receptor status in the analyses because the information
was not available for all records. Furthermore, some of the
risk estimates were based on small numbers of subjects,
especially for some categories of supplementation; there-
fore, some of the significant associations may be due to
due to chance.
The recommended intakes (recommended dietary allow-
ance) for adult women are 700 μg/day for vitamin A, 15
mg/day for vitamin E, 75 mg/day for vitamin C, 55 μg/day
for selenium and 8 mg/day for zinc [46]. Canadian nutri-
tion survey in 2004 data showed that percentages of adult
women 19 years or over with a usual intake below the
Table 4 ORs of breast cancer associated with supplementation of antioxidants, NECSS,Canada,1994-1997
Premenopausal Postmenopausal
Variable Cases Controls OR † (95% CI) p trend Cases Controls OR†† (95% CI) p trend
Multiple vitamin (years) 0.53 0.04
0 (never taken)* 269 249 1.00 654 731 1.00
≤ 2 year 282 294 0.86 (0.67-1.10) 312 335 0.91 (0.75-1.11)
3-9 year 180 177 0.85 (0.64-1.13) 292 268 1.03 (0.83-1.27)
≥ 10 years 135 125 0.93 (0.69-1.27) 238 283 0.74 (0.59-0.92)
Vitamin A (years) 0.26 0.31
0 (never taken)* 690 677 1.00 1235 1350 1.00
≤ 2 year 105 95 1.02 (0.75-1.39) 127 133 0.90 (0.69-1.19)
3-9 year 47 40 1.03 (0.65-1.61) 72 61 1.12 (0.77-1.63)
≥ 10 years 24 33 0.61 (0.35-1.06) 62 73 0.77 (0.53-1.11)
Beta-carotene (years) # 0.86 0.15
0 (never taken)* 675 689 1.00 1219 1348 1.00
≤ 2 year 144 93 1.54 (1.16-2.06) 182 162 1.01 (0.79-1.29)
3-9 year 35 42 0.85 (0.53-1.37) 63 60 1.01 (0.69-1.49)
≥ 10 years 12 21 0.51 (0.24-1.06) 32 47 0.58 (0.36-0.95)
Vitamin C (years) # 0.26 0.07
0 (never taken)* 337 357 1.00 687 792 1.00
≤ 2 year 267 223 1.20 (0.94-1.53) 306 317 0.86 (0.70-1.05)
3-9 year 165 148 1.08 (0.82-1.43) 268 261 0.96 (0.77-1.19)
≥ 10 years 97 117 0.75 (0.54-1.03) 235 247 0.79 (0.63-0.99)
Vitamin E (years) # 0.25 0.05
0 (never taken)* 493 513 1.00 822 935 1.00
≤ 2 year 245 171 1.46 (1.15-1.85) 316 286 1.05 (0.86-1.28)
3-9 year 89 113 0.73 (0.53-1.01) 209 220 0.91 (0.72-1.15)
≥ 10 years 39 48 0.74 (0.47-1.17) 149 176 0.75 (0.58-0.97)
Zinc (years) # 0.004 0.02
0 (never taken)* 736 688 1.00 1297 1420 1.00
≤ 2 year 85 95 0.81 (0.58-1.11) 120 94 1.14 (0.84-1.53)
3-9 year 27 33 0.73 (0.43-1.25) 52 56 0.83 (0.55-1.26)
≥ 10 years 18 29 0.46 (0.25-0.85) 27 47 0.47 (0.28-0.78)
Selenium (years) # 0.59 0.85
0 (never taken)* 755 754 1.00 1355 1504 1.00
≤ 2 year 85 50 1.65 (1.13-2.40) 88 56 1.43 (0.98-2.05)
3-9 year 16 27 0.59 (0.31-1.12) 29 30 0.90 (0.52-1.57)
≥ 10 years 10 14 0.57 (0.25-1.34) 24 27 0.75 (0.42-1.34)
* Reference category
† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, number of live births, age at menarche, and total energy intake.
†† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, BMI, recreational physical activity, number of live births, age at
menarche, and total energy intake.
# also adjusted for antioxidant intake from diet.
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Page 8 of 12Table 5 ORs of breast cancer associated with total intake of antioxidants, NECSS,Canada,1994-1997
Premenopausal Postmenopausal
Variable Cases Controls OR † (95% CI) p Cases Controls OR†† (95% CI) p
Beta-carotene
From Diet only
Low or no intake 423 435 1.00 781 837 1.00
High intake * 443 410 1.09 (0.88-1.34) 0.43 715 780 0.96 (0.82-1.13) 0.66
From supplementation only
Low or no intake 864 836 1.00 1487 1598 1.00
High intake** 2 9 0.11 (0.01-0.88) 0.04 9 19 0.47 (0.20-1.08) 0.07
From both sources
Low or no intake 856 833 1.00 1473 1589 1.00
High intake*** 10 12 0.77 (0.32-1.87) 0.57 23 28 0.69 (0.37-1.27) 0.23
Vitamin C (years)
From Diet only
Low or no intake 467 489 1.00 861 962 1.00
High intake * 399 356 1.23 (0.99-1.53) 0.06 635 655 1.24 (0.99-1.42) 0.07
From supplementation only
Low or no intake 823 794 1.00 1405 1524 1.00
High intake** 43 51 0.70 (0.44-1.10) 0.12 91 93 0.85 (0.61-1.17) 0.32
From both sources
Low or no intake 812 779 1.00 1352 1463 1.00
High intake*** 54 66 0.65 (0.44-0.98) 0.04 144 154 0.78 (0.60-1.03) 0.08
Vitamin E (years)
From Diet only
Low or no intake 451 454 1.00 837 922 1.00
High intake * 415 391 0.98 (0.78-1.22) 0.85 659 695 1.06 (0.89-1.25) 0.53
From supplementation only
Low or no intake 852 828 1.00 1451 1555 1.00
High intake** 14 17 0.72 (0.33-1.59) 0.42 45 62 0.64 (0.42-0.99) 0.04
From both sources
Low or no intake 841 814 1.00 1392 1503 1.00
High intake*** 25 31 0.71 (0.40-1.25) 0.23 104 114 0.86 (0.64-1.17) 0.35
Zinc (years)
From Diet only
Low or no intake 430 451 1.00 747 855 1.00
High intake * 436 394 1.13 (0.89-1.45) 0.32 749 762 1.13 (0.94-1.35) 0.20
From supplementation only
Low or no intake 859 830 1.00 1487 1597 1.00
High intake** 7 15 0.29 (0.10-0.83) 0.02 9 20 0.41 (0.18-0.96) 0.04
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2Table 5 ORs of breast cancer associated with total intake of antioxidants, NECSS,Canada,1994-1997 (Continued)
From both sources
Low or no intake 855 831 1.00 1478 1590 1.00
High intake*** 11 14 0.73 (0.31-1.72) 0.47 18 27 0.51 (0.27-0.97) 0.04
Selenium (years)
From Diet only
Low or no intake 417 426 1.00 747 822 1.00
High intake * 449 419 1.01 (0.79-1.29) 0.93 749 795 0.99 (0.82-1.18) 0.88
From supplementation only
Low or no intake 861 834 1.00 1488 1604 1.00
High intake** 5 11 0.39 (0.13-1.16) 0.09 8 13 0.50 (0.19-1.32) 0.16
From both sources
Low or no intake 861 842 1.00 1480 1603 1.00
High intake*** 5 3 1.77 (0.33-9.69) 0.51 16 14 0.82 (0.37-1.80) 0.61
† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, number of live births, age at menarche, and total energy intake.
†† Adjusted for age, province of residence, education, smoking pack years, alcohol consumption, BMI, recreational physical activity, number of live births, age at menarche, and total energy intake.
* In comparison with low intake (lower than median intake).
** In comparison with low intake (less than 10 years of supplementation).
*** In comparison with not high intake from both sources.
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2estimated average requirement were 35.8% for vitamin A,
16.7% for vitamin C and 14.0% for zinc [47]. Our data
showed that the average dietary intake for the study popu-
lation had reached the recommended dietary allowance
for vitamin C, selenium and zinc, but was lower for vita-
min E.
Conclusion
In summary, our population-based study showed that
supplementation of 10 years or longer of certain antioxi-
dants such as beta-carotene, vitamin C, vitamin E and
zinc may reduce the risk of breast cancer, although this
study could not determine the overall effect of total
dose or intake of antioxidants from both diet and sup-
plement. Further investigations are warranted to confirm
our results. The findings of our study may shed light on
the prevention and control of breast cancer.
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